TJ
Therapeutic Areas
CytoMed Therapeutics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| CTM-N2D | Various Solid Tumors | Preclinical |
| CTM-N2D-001 | Various Solid Tumors | Phase 1 |
| CTM-PNK | Hematological Cancers | Preclinical |
| iPSC-γδ NKT Cells | Cancer (Broad Spectrum) | Research |
| Drug | Indication | Phase |
|---|---|---|
| CTM-N2D | Various Solid Tumors | Preclinical |
| CTM-N2D-001 | Various Solid Tumors | Phase 1 |
| CTM-PNK | Hematological Cancers | Preclinical |
| iPSC-γδ NKT Cells | Cancer (Broad Spectrum) | Research |